Intech Investment Management LLC Acquires Shares of 44,379 LifeStance Health Group, Inc. (NASDAQ:LFST)

Intech Investment Management LLC acquired a new stake in LifeStance Health Group, Inc. (NASDAQ:LFST) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 44,379 shares of the company’s stock, valued at approximately $311,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Jennison Associates LLC boosted its stake in LifeStance Health Group by 9.5% in the third quarter. Jennison Associates LLC now owns 2,136,942 shares of the company’s stock valued at $14,959,000 after acquiring an additional 184,896 shares during the last quarter. Principal Financial Group Inc. boosted its stake in LifeStance Health Group by 6.1% in the third quarter. Principal Financial Group Inc. now owns 4,116,766 shares of the company’s stock valued at $28,817,000 after acquiring an additional 235,316 shares during the last quarter. Park Edge Advisors LLC bought a new position in LifeStance Health Group in the third quarter valued at approximately $73,000. SG Americas Securities LLC boosted its stake in LifeStance Health Group by 406.4% in the third quarter. SG Americas Securities LLC now owns 54,532 shares of the company’s stock valued at $382,000 after acquiring an additional 43,763 shares during the last quarter. Finally, Point72 Asset Management L.P. bought a new position in LifeStance Health Group in the second quarter valued at approximately $4,326,000. 85.50% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on LFST. UBS Group reduced their price target on shares of LifeStance Health Group from $9.00 to $7.50 and set a “neutral” rating on the stock in a research report on Thursday, August 15th. Barclays lifted their price target on shares of LifeStance Health Group from $6.00 to $7.00 and gave the stock an “underweight” rating in a research report on Monday, November 11th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $8.50.

Insider Buying and Selling at LifeStance Health Group

In other LifeStance Health Group news, Director Robert Bessler sold 75,000 shares of LifeStance Health Group stock in a transaction on Wednesday, November 27th. The shares were sold at an average price of $7.54, for a total value of $565,500.00. Following the sale, the director now directly owns 1,424,447 shares in the company, valued at approximately $10,740,330.38. The trade was a 5.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 6.60% of the company’s stock.

LifeStance Health Group Trading Down 1.7 %

LFST opened at $7.33 on Thursday. The stock has a market capitalization of $2.80 billion, a P/E ratio of -28.77 and a beta of 1.28. LifeStance Health Group, Inc. has a 12 month low of $4.64 and a 12 month high of $9.20. The firm’s fifty day simple moving average is $7.11 and its 200 day simple moving average is $6.27. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.19.

LifeStance Health Group (NASDAQ:LFST) last issued its quarterly earnings results on Thursday, November 7th. The company reported ($0.02) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.07) by $0.05. LifeStance Health Group had a negative net margin of 7.90% and a negative return on equity of 6.66%. The firm had revenue of $312.70 million for the quarter, compared to analyst estimates of $302.25 million. During the same period in the previous year, the business earned ($0.17) EPS. The company’s revenue was up 18.9% compared to the same quarter last year. As a group, research analysts anticipate that LifeStance Health Group, Inc. will post -0.22 EPS for the current fiscal year.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.